Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis.
Rouvinov K, Levanon E, Peer A, Sarfaty M, Sarid D, Neiman V, Grikshtas E, Rosenbaum E, Kushnir I, Talmor B, Friger M, Zarbiv Y, Gez E, Dresler H, Shalata W, Meirovitz A, Shrem NS, Yakobson A, Mermershtain W, Keizman D. Rouvinov K, et al. Among authors: meirovitz a. Front Oncol. 2023 May 24;13:1151701. doi: 10.3389/fonc.2023.1151701. eCollection 2023. Front Oncol. 2023. PMID: 37293597 Free PMC article.
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms".
Chatzellis E, Daskalakis K, Angelousi A, Tsoli M, Alexandraki KI, Wachula E, Meirovitz A, Maimon O, Grozinsky-Glasberg S, Gross D, Kos-Kudła B, Koumarianou A, Kaltsas G. Chatzellis E, et al. Among authors: meirovitz a. Neuroendocrinology. 2020;110(1-2):158-160. doi: 10.1159/000503999. Epub 2019 Oct 10. Neuroendocrinology. 2020. PMID: 31597137 No abstract available.
Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.
McLaughlin PW, Narayana V, Meirovitz A, Troyer S, Roberson PL, Gonda R Jr, Sandler H, Marsh L, Lawrence T, Kessler M. McLaughlin PW, et al. Among authors: meirovitz a. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):20-31. doi: 10.1016/j.ijrobp.2004.04.070. Int J Radiat Oncol Biol Phys. 2005. PMID: 15629590
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
Pierce LJ, Phillips KA, Griffith KA, Buys S, Gaffney DK, Moran MS, Haffty BG, Ben-David M, Kaufman B, Garber JE, Merajver SD, Balmaña J, Meirovitz A, Domchek SM. Pierce LJ, et al. Among authors: meirovitz a. Breast Cancer Res Treat. 2010 Jun;121(2):389-98. doi: 10.1007/s10549-010-0894-z. Epub 2010 Apr 22. Breast Cancer Res Treat. 2010. PMID: 20411323 Free PMC article.
Warfarin skin necrosis: local and systemic factors.
Ad-El DD, Meirovitz A, Weinberg A, Kogan L, Arieli D, Neuman A, Linton D. Ad-El DD, et al. Among authors: meirovitz a. Br J Plast Surg. 2000 Oct;53(7):624-6. doi: 10.1054/bjps.2000.3402. Br J Plast Surg. 2000. PMID: 11000083
91 results